NADA Number: 141-105 | |
| Proprietary Name |
Program® 6 Month Injectable for Cats |
|---|---|
| Sponsor |
Novartis Animal Health US, Inc. |
| Sponsor Address |
3200 Northline Ave, Suite 300 Greensboro, NC 27408 USA |
| Ingredients |
Lufenuron |
| Species |
Cat, excluding under 6 weeks age |
| Routes of Administration |
Subcutaneous |
| Dose Form |
Liquid (suspension) |
| Drug Form |
Liquid (suspension) |
| Dispensing Status |
RX |
| Patent Number |
4798837 5416102 5420163 |
| Exclusivity |
Granted for the control of flea populations in cats six weeks of age and older. Route of administration: subcutaneous injection for control of fleas for 6 months. |
|
Dosage Amount, Indications & Limitations |
522.1289 Lufenuron suspension. Specifications: Each milliliter of sterile aqueous suspension contains 10 milligrams of lufenuron. Conditions of use: Cats Amount: 10 milligrams per kilogram (4.5 milligrams per pound) of body weight every 6 months, subcutaneously. Indications: For use in cats 6 weeks of age and older, for control of flea populations. Lufenuron controls flea populations by preventing the development of flea eggs and does not kill adult fleas. Concurrent use of insecticides may be necessary for adequate control of adult fleas. Limitations: The safety of this product in reproducing animals has not been established. Do not use in dogs. Federal law restricts this drug to use by or on the order of a licensed veterinarian. |